Genome wide association studies (GWAS) have been a powerful tool in revealing many loci that 4 4
influence complex traits and diseases. However, most SNP associations map to non-coding regions of the 4 5 genome, thereby complicating the task of identifying the (causal) genes through which the observed 4 6 effects on disease predisposition are mediated 1 . To address this challenge, researchers have implemented 4 7 a variety of approaches to link regulatory variants implicated in disease predisposition to their 4 8 downstream effectors. One of the most widely adopted approaches leverages expression quantitative trait 1 0 0 enzymes, transporters, and regulators that can be directly tied to the specific metabolite, based on known 1 0 1 functional relationships. These provide a "truth" gene set that can then be used to assess the performance 1 0 2 (i.e. sensitivity and positive predictive value) of alternative analytical approaches for identifying effector 1 0 3 transcripts, and which can inform the utility of applying TWAS approaches to the interpretation of GWAS data for other complex traits. Genotype data (variant call format), gene expression (quantified gene-level counts), and sample 1 1 0 phenotype data from GTEx version 7 were obtained through dbGaP accession phs000424.v7.p2 22 .
1 1 1 forward for analysis. Remaining genes were TMM normalised, then log transformed to counts per million 1 1 7
using Voom 23 . Surrogate variables were calculated after explicitly defining sex in the models, and 1 1 8
residual expression values after regressing out all surrogate variables and sex were used for analyses 24 .
1 1 9
Cis-eQTLs analysis was performed using QTLtools (Version 1.1) with a cis-distance limit of 1,000,000 further analysis due to poor model fit. For each modelled gene, S-PrediXcan (version 0.5.4) was used to calculate a z-score, which is a linear 1 5 4 model of SNP effects for all SNPs in the gene's final ridge regression model described above 14 . Each SNP's effect is the product of its expression association coefficient, its GWAS z-score, and a SNP 1 5 6 variance term (the SNP's standard error divided by the standard error of the gene's predicted expression). The SNP expression association coefficients used were those resulting from the final filtered gene 1 5 8 each significant S-PrediXcan gene using GCTA (version 1. 26.0) 28 . Each lead SNP effect was conditioned 1 6 7 out of the GWAS summary data. S-PrediXcan was then performed as previously described, excluding the 1 6 8 SNP/s being conditioned on, and using the GWAS z-scores resulting from the conditional GWAS 1 6 9
analysis. in this database were referenced to assess membership of significant S-PrediXcan associated genes. Metabolic pathways and GO classifications annotated to novel genes were compared with those for 1 7 6
putative causal genes associated to the same metabolites to assess shared metabolic processes. To investigate gene associations based on multi-SNP models, we first evaluated the extent to which these 1 8 2 models improve prediction of gene expression relative to single variant models. We obtained single There were 20 of the 61 gene-metabolite pairs in the truth set that did not yield significant S-PrediXcan 3 4 4 associations in any tissue. However, for 15 of these, significant S-PrediXcan associations (from the set of 3 4 5 514 gene-metabolite pairs described above) were seen for nearby bystander genes in at least one tissue, 3 4 6
with eight of these showing significant bystander gene colocalization (Table S4) . Taken together with the 3 4 7 results for the 41 true positive signals, these analyses indicate substantial pleiotropy at the level of cis-
respectable sensitivity in detecting the causal gene in these data, performance in terms of PPV is poor and 4 0 0 additional lines of evidence will be needed at most loci to establish causality. In this study, we have assessed the utility of multi-SNP prediction models for explaining variation in gene 4 0 5 expression and their application in transcriptome-wide association analysis (TWAS). We quantified the 4 0 6 extent to which these models outperform expression models based on a single eQTL, demonstrating, 4 1 4
We found that, notwithstanding the use of LASSO regression as a sparse form of variable selection, it is 4 1 5 still prone to select sets of SNPs that are highly correlated, introducing multicollinearity into resulting 4 1 6 regression models. This notion has been described before in real and simulated GWAS data 32 . We showed 4 1 7 that a simple iterative approach to LASSO modelling that involved LD-based filtering resulted in 4 1 8
increased model sparsity and decreased multicollinearity, leading to more confident genetic instruments 4 1 9
for gene expression. Despite the improved performance in predicting gene expression attributable to models with multiple, 4 2 2
independent SNPs, we found that, using available GTEx data, TWAS associations based on these models 4 2 3
were, in most instances, driven by a single SNP within each trait-associated locus: 90% of associations 4 2 4
were no longer significant after stepwise conditional analysis. Although this proportion is likely to fall as 4 2 5 eQTL sample sizes increase (increasing the power to detect the additional impact of conditioned variants), 4 2 6
these results indicate that, for many genes, the increment in power gained by moving from single to multi-4 2 7
SNP analyses is modest. The genetic architecture underlying metabolite traits provides a unique opportunity to quantify the 4 3 0 performance of gene associations based on multi-SNP models. By leveraging a "truth" set of 4 3 1 experimentally validated genes linked to metabolites, we have shown, using GTEx, that TWAS has gene but also five other genes at the same locus, all of which are associated with glutarylcarnitine levels 4 3 9
in TWAS. These insights temper the extent to which it can be assumed that genes implicated by leverages molecular pathway annotations whereas TWAS is agnostic to this information. Accordingly, 4 5 5
ProGeM is intended for a specific trait class -molecular QTLs (e.g. metabolites, lipids, proteins) -and the 4 5 6
incorporation of additional information relevant to metabolites is likely to have contributed to the better Our analyses were focused on the use of expression QTLs to map causal genes at metabolomic-QTL TWAS approaches provide an attractive option for prioritizing candidate genes at trait-associated loci.
7 4
Here, we have demonstrated the potential for these approaches to identify associations that are not causal, Ultimately, the process of identifying causal genes at GWAS signals represents an integrative enterprise 4 7 7
that is dependent on combining results from multiple complementary approaches, including, in addition to 4 7 8 QTL-mapping, epigenome profiling (e.g. chromatin co-accessibility or conformation capture methods), 4 7 9 functional screens (e.g. high-throughput gene knock-out CRISPR screens) and the detection of coding 4 8 0 variant associations. All of these prioritization approaches -including TWAS -will become more 4 8 1 accurate, as the data sets available encompass a wider range of tissues and cell types captured in TWAS. Of the 61 high confidence truth set genes, 41 had significant S-PrediXcan associations in at least 6 5 1 one tissue. a Eight gene-metabolite pairs that had a significant association in liver. 
